Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)

• Main Authors: Ma, Brigette BY, Lim, Wan-Teck, Goh, Boon-Cher, Hui, Edwin P, Lo, Kwok-Wai, Pettinger, Adam, Foster, Nathan R, Riess, Jonathan W, Agulnik, Mark, Chang, Alex YC, Chopra, Akhil, Kish, Julie A, Chung, Christine H, Adkins, Douglas R, Cullen, Kevin J, Gitlitz, Barbara J, Lim, Dean W, To, Ka-Fai, Chan, KC Allen, Lo, YM Dennis, King, Ann D, Erlichman, Charles, Yin, Jun, Costello, Brian A, Chan, Anthony TC
• Other Authors: MEDICINE
• Format: Article
• Language: English
• Published: AMER SOC CLINICAL ONCOLOGY 2024
• Subjects: Science & Technology; Life Sciences & Biomedicine; Oncology; BARR-VIRUS DNA; PD-L1 EXPRESSION; CELL CARCINOMA; THERAPY; CANCER; MELANOMA; MUTATIONS; BLOCKADE; ESCAPE; SUBSET
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/248960
• Institution: National University of Singapore

10.1200/JCO.2017.77.0388